Nelson DB, Rice DC, Mitchell KG, Tsao AS, Vaporciyan AA, Antonoff MB, Hofstetter WL, Walsh GL, Swisher SG , Roth JA, Gomez DR, Mehran RJ, Sepesi B
true safety depends on individual health, treatment history, and dosage
"In vitro folding, functional characterization, and disulfide pattern of the extracellular domain of human GLP-1 receptor"
It works by inhibiting bacterial cell wall synthesis, making it effective against a wide range of gram-positive and gram-negative bacteria, including some strains resistant to other antibiotics
The most common infectious agents causing hemolysis include Salmonella, Escherichia coli, beta-hemolytic streptococci, rickettsial infections, viral hepatitis, and influenza A